126 related articles for article (PubMed ID: 1310311)
1. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites.
Knaus HG; Moshammer T; Kang HC; Haugland RP; Glossmann H
J Biol Chem; 1992 Feb; 267(4):2179-89. PubMed ID: 1310311
[TBL] [Abstract][Full Text] [Related]
2. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: evidence for a functional, extracellular heparin-binding site.
Knaus HG; Moshammer T; Friedrich K; Kang HC; Haugland RP; Glossman H
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3586-90. PubMed ID: 1314393
[TBL] [Abstract][Full Text] [Related]
3. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer.
Berger W; Prinz H; Striessnig J; Kang HC; Haugland R; Glossmann H
Biochemistry; 1994 Oct; 33(39):11875-83. PubMed ID: 7918406
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.
Vaghy PL; Striessnig J; Miwa K; Knaus HG; Itagaki K; McKenna E; Glossmann H; Schwartz A
J Biol Chem; 1987 Oct; 262(29):14337-42. PubMed ID: 2443504
[TBL] [Abstract][Full Text] [Related]
5. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.
Brauns T; Prinz H; Kimball SD; Haugland RP; Striessnig J; Glossmann H
Biochemistry; 1997 Mar; 36(12):3625-31. PubMed ID: 9132014
[TBL] [Abstract][Full Text] [Related]
6. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
Goll A; Glossmann H; Mannhold R
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):303-12. PubMed ID: 3027587
[TBL] [Abstract][Full Text] [Related]
8. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
10. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
11. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
Striessnig J; Knaus HG; Glossmann H
Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyridine and phenylalkylamine receptors associated with cardiac and skeletal muscle calcium channels are structurally different.
Chang FC; Hosey MM
J Biol Chem; 1988 Dec; 263(35):18929-37. PubMed ID: 2848812
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
15. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding.
Ebata H; Mills JS; Nemcek K; Johnson JD
J Biol Chem; 1990 Jan; 265(1):177-82. PubMed ID: 2152918
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
Striessnig J; Murphy BJ; Catterall WA
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
[TBL] [Abstract][Full Text] [Related]
18. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
[TBL] [Abstract][Full Text] [Related]
19. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
Glossmann H; Ferry DR
Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
[TBL] [Abstract][Full Text] [Related]
20. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
